Biotech: ‘Unprecedented Times,’ Not a Bubble

Credit Suisse analyst Ravi Mehrotra and team don’t think biotech stocks–including Biogen Idec (BIIB) and Celgene (CELG)–are in a bubble. He explains why: Bloomberg News Given the unprecedented performance in the biotech sector – are we in a “biotech bubble”? One thing is for sure – we are in a completely unprecedented times for the [...]